|
US1532178A
(en)
|
1921-07-25 |
1925-04-07 |
Louis A Godbold |
Lubricator
|
|
FR1260080A
(fr)
|
1960-03-22 |
1961-05-05 |
Materiel De Forage Soc De Fab |
Trépan à molettes étanche
|
|
US3647809A
(en)
|
1968-04-26 |
1972-03-07 |
Chinoin Gyogyszer Es Vegyeszet |
Certain pyridyl-1 2 4-oxadiazole derivatives
|
|
US4022901A
(en)
|
1975-03-05 |
1977-05-10 |
E. R. Squibb & Sons, Inc. |
3-Pyridinyl-5-isothiocyanophenyl oxadiazoles
|
|
US4264573A
(en)
|
1979-05-21 |
1981-04-28 |
Rowell Laboratories, Inc. |
Pharmaceutical formulation for slow release via controlled surface erosion
|
|
US4386668A
(en)
|
1980-09-19 |
1983-06-07 |
Hughes Tool Company |
Sealed lubricated and air cooled rock bit bearing
|
|
DK175069B1
(da)
|
1986-03-11 |
2004-05-24 |
Hoffmann La Roche |
Pyrocatecholderivater
|
|
US5236952A
(en)
|
1986-03-11 |
1993-08-17 |
Hoffmann-La Roche Inc. |
Catechol derivatives
|
|
YU213587A
(en)
|
1986-11-28 |
1989-06-30 |
Orion Yhtymae Oy |
Process for obtaining new pharmacologic active cateholic derivatives
|
|
DE3840954A1
(de)
|
1988-12-05 |
1990-06-07 |
Shell Int Research |
Herstellung von 2-chlornicotinsaeureestern
|
|
US5206372A
(en)
|
1990-06-05 |
1993-04-27 |
Shell Research Limited |
Preparation of 2-chloropyridine derivatives
|
|
ES2066092T3
(es)
|
1990-11-29 |
1995-03-01 |
Wei Ming Pharmaceutical Mfg Co |
Coadyuvante para la formacion directa de comprimidos.
|
|
EP0619814A1
(en)
|
1991-12-31 |
1994-10-19 |
Fujisawa Pharmaceutical Co., Ltd. |
Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity
|
|
FR2730322B1
(fr)
|
1995-02-02 |
1997-04-30 |
Imago |
Monture de lunettes metallique
|
|
DE19628617A1
(de)
|
1996-07-16 |
1998-01-22 |
Basf Ag |
Direkttablettierhilfsmittel
|
|
US6206110B1
(en)
|
1996-09-09 |
2001-03-27 |
Smith International, Inc. |
Protected lubricant reservoir with pressure control for sealed bearing earth boring drill bit
|
|
JP2002526482A
(ja)
|
1998-09-18 |
2002-08-20 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ｐ３８のインヒビター
|
|
GB2344819A
(en)
|
1998-12-18 |
2000-06-21 |
Portela & Ca Sa |
2-Phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones
|
|
FI109453B
(fi)
|
1999-06-30 |
2002-08-15 |
Orion Yhtymae Oyj |
Farmaseuttinen koostumus
|
|
IL131037A
(en)
|
1999-07-22 |
2004-06-20 |
Israel Atomic Energy Comm |
Method for making threedimensional photonic band-gap crystals
|
|
KR100875222B1
(ko)
|
1999-08-19 |
2008-12-19 |
아스트라제네카 아베 |
헤테로폴리사이클릭 화합물 및 간접 글루타메이트 수용체길항제로서의 그들의 용도
|
|
US6660753B2
(en)
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
EP1248869A2
(en)
*
|
2000-01-07 |
2002-10-16 |
Transform Pharmaceuticals, Inc. |
High-throughput formation, identification, and analysis of diverse solid-forms
|
|
FI20000635A0
(fi)
|
2000-03-17 |
2000-03-17 |
Orion Yhtymae Oyj |
COMT-inhibiittoreiden käyttö analgeettina
|
|
SE0001438D0
(sv)
|
2000-04-18 |
2000-04-18 |
Axon Chemicals Bv |
New chemical compounds and their use in therapy
|
|
DE10029201A1
(de)
|
2000-06-19 |
2001-12-20 |
Basf Ag |
Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
|
|
GB2363792A
(en)
|
2000-06-21 |
2002-01-09 |
Portela & Ca Sa |
Nitrocatechols
|
|
EP1329825A4
(en)
|
2000-08-24 |
2006-03-22 |
Sagawa Express Co Ltd |
CARD PAYMENT PROCEDURE FOR SERVICE FEES RELATING TO PHYSICAL DISTRIBUTION OR TRANSPORT
|
|
CN1166626C
(zh)
|
2000-08-30 |
2004-09-15 |
李凌松 |
三或四取代苯基化合物、其制备方法及应用
|
|
WO2002051442A1
(en)
|
2000-12-26 |
2002-07-04 |
Takeda Chemical Industries, Ltd. |
Concomitant drugs
|
|
US20040097555A1
(en)
|
2000-12-26 |
2004-05-20 |
Shinegori Ohkawa |
Concomitant drugs
|
|
MXPA03007513A
(es)
|
2001-02-21 |
2004-07-30 |
Nps Pharma Inc |
Compuestos heteropoliciclicos y su uso como antagonistas del receptor metabotropico de glutamato.
|
|
WO2002096867A2
(en)
|
2001-05-30 |
2002-12-05 |
Lg Biomedical Institute |
Inhibitors of protein kinase for the treatment of disease
|
|
JP2005504014A
(ja)
|
2001-06-08 |
2005-02-10 |
サイトビア インコーポレイテッド |
カスパーゼの活性化因子およびアポトーシスの誘導因子としての置換された３−アリール−５−アリール−［１，２，４］−オキサジアゾール類および類似体、並びにその使用法
|
|
US6627646B2
(en)
*
|
2001-07-17 |
2003-09-30 |
Sepracor Inc. |
Norastemizole polymorphs
|
|
PT1408964E
(pt)
|
2001-07-26 |
2007-05-31 |
Merck Patent Gmbh |
Utilização de 2-5-(4-fluorofenil) -3-piridilmetilaminometil-cromano e de seus sais fisiologicamente aceitáveis.
|
|
JP4379853B2
(ja)
|
2001-10-05 |
2009-12-09 |
惠民製藥股▲分▼有限公司 |
直接錠剤化用調合物および補助剤の調合方法
|
|
CN100364531C
(zh)
|
2002-12-18 |
2008-01-30 |
西托维亚公司 |
3,5－二取代－[1,2,4]－二唑及类似物和其用途
|
|
WO2005006945A2
(en)
|
2003-07-03 |
2005-01-27 |
The Salk Institute For Biological Studies |
Methods for treating neural disorders and compounds useful therefor
|
|
WO2005013982A1
(en)
|
2003-08-06 |
2005-02-17 |
Vertex Pharmaceuticals Incorporated |
Aminotriazole compounds useful as inhibitors of protein kinases
|
|
US7300406B2
(en)
|
2003-09-30 |
2007-11-27 |
Carter Vandette B |
Medical examination apparatus
|
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
|
WO2005105780A2
(en)
|
2004-04-28 |
2005-11-10 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of rock and other protein kinases
|
|
GB0510143D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds A1
|
|
US20060173074A1
(en)
|
2004-11-10 |
2006-08-03 |
Juha Ellmen |
Treatment of restless legs syndrome
|
|
WO2006061697A1
(en)
|
2004-12-06 |
2006-06-15 |
Themis Laboratories Private Limited |
Sulfonylurea compositions and a process for its preparation
|
|
WO2006071184A1
(en)
|
2004-12-28 |
2006-07-06 |
Astrazeneca Ab |
Aryl sulphonamide modulators
|
|
US20080051441A1
(en)
|
2004-12-28 |
2008-02-28 |
Astrazeneca Ab |
Aryl Sulphonamide Modulators
|
|
US8017631B2
(en)
|
2005-04-26 |
2011-09-13 |
Neurosearch A/S |
Oxadiazole derivatives and their medical use
|
|
US20060257473A1
(en)
|
2005-05-11 |
2006-11-16 |
Porranee Puranajoti |
Extended release tablet
|
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
|
US7553964B2
(en)
|
2005-06-03 |
2009-06-30 |
Abbott Laboratories |
Cyclobutyl amine derivatives
|
|
US20090000437A1
(en)
|
2005-07-14 |
2009-01-01 |
Provo Craft And Novelty, Inc. |
Methods for Cutting
|
|
PL1907382T3
(pl)
|
2005-07-26 |
2016-01-29 |
Bial Portela & Ca Sa |
Pochodne nitrokatecholowe jako inhibitory COMT
|
|
FR2889525A1
(fr)
|
2005-08-04 |
2007-02-09 |
Palumed Sa |
Nouveaux derives de polyquinoleines et leur utilisation therapeutique.
|
|
US20070048384A1
(en)
|
2005-08-26 |
2007-03-01 |
Joerg Rosenberg |
Pharmaceutical compositions
|
|
EP1954137A4
(en)
|
2005-11-18 |
2008-12-17 |
Janssen Pharmaceutica Nv |
2-KETO-OXAZOLE AS MODULATORS OF FATTY ACID AMIDHYDROLASE
|
|
WO2007063946A1
(ja)
|
2005-11-30 |
2007-06-07 |
Fujifilm Ri Pharma Co., Ltd. |
アミロイドの凝集及び／又は沈着に起因する疾患の診断薬及び治療薬
|
|
GB0606774D0
(en)
|
2006-04-03 |
2006-05-10 |
Novartis Ag |
Organic compounds
|
|
EP1845097A1
(en)
|
2006-04-10 |
2007-10-17 |
Portela & Ca., S.A. |
Oxadiazole derivatives as COMT inhibitors
|
|
PE20080906A1
(es)
|
2006-08-17 |
2008-07-05 |
Kemia Inc |
Derivados heteroarilo como inhibidores de citocina
|
|
US20080167286A1
(en)
|
2006-12-12 |
2008-07-10 |
Abbott Laboratories |
Pharmaceutical compositions and their methods of use
|
|
US8486979B2
(en)
|
2006-12-12 |
2013-07-16 |
Abbvie Inc. |
1,2,4 oxadiazole compounds and methods of use thereof
|
|
JP2008162955A
(ja)
|
2006-12-28 |
2008-07-17 |
Chugai Pharmaceut Co Ltd |
バリン含有高密度顆粒剤
|
|
BRPI0721213B1
(pt)
|
2007-01-31 |
2021-11-09 |
Bial - Portela & Ca, S.A. |
Uso de nitrocatecóis substituídos, e embalagem
|
|
AR065802A1
(es)
|
2007-03-22 |
2009-07-01 |
Schering Corp |
Formulaciones de comprimidos que contienen sales de 8- [( 1- ( 3,5- bis- (trifluorometil) fenil) -etoxi ) - metil) -8- fenil -1, 7- diaza- spiro [ 4,5] decan -2- ona y comprimidos elaborados a partir de estas
|
|
KR101669432B1
(ko)
|
2007-08-27 |
2016-10-26 |
다트 뉴로사이언스 (케이만) 엘티디. |
치료적 이속사졸 화합물
|
|
MX2010009043A
(es)
*
|
2008-02-28 |
2010-10-25 |
Bial Portela & Ca Sa |
Composicion farmaceutica para farmacos poco solubles.
|
|
WO2009116882A1
(en)
|
2008-03-17 |
2009-09-24 |
Portela & Ca., S.A. |
Crystal forms of 5- [3- (2, 5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl) [1,2,3] oxadiazol-5-yl] -3-nit robenzene-1, 2-diol
|
|
ES2723729T3
(es)
|
2008-07-29 |
2019-08-30 |
Bial Portela & Ca Sa |
Régimen de administración de nitrocatecoles
|
|
US8827197B2
(en)
|
2008-11-04 |
2014-09-09 |
Microgreen Polymers Inc |
Apparatus and method for interleaving polymeric roll for gas impregnation and solid-state foam processing
|
|
PT2413912T
(pt)
|
2009-04-01 |
2019-06-11 |
Bial Portela & Ca Sa |
Formulações farmacêuticas compreendendo derivados de nitrocatecol e métodos para as produzir
|
|
BRPI1016132B8
(pt)
|
2009-04-01 |
2021-05-25 |
Bial Portela & Ca Sa |
composição, formulação farmacêutica, processo de obtenção de uma formulação farmacêutica estável
|
|
EA026419B1
(ru)
|
2010-03-04 |
2017-04-28 |
Орион Корпорейшн |
Применение леводопы, карбидопы и энтакапона для лечения болезни паркинсона
|
|
US20140045900A1
(en)
|
2011-02-11 |
2014-02-13 |
Bial-Portela & Ca, S.A. |
Administration regime for nitrocatechols
|
|
JP6456143B2
(ja)
|
2011-12-13 |
2019-01-23 |
ノヴィファーマ，エス．アー． |
カテコール−ｏ−メチル転移酵素阻害剤を調製するための中間体として有用な化学的化合物
|